Paglinawan, Tessa Mae L.
HRN: 20-59-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/08/2023
07/14/2023
IV
4.5g
Q6h
Severe Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes